World News
Business
Investing
Stocks

World News
Business
Investing
Stocks

Home Investing RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

June 4, 2025

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

previous post

Triumph Gold Announces the Acquisition of the Coyote Knoll Silver-Gold Mineral Property – Located in Central Utah

next post

Adam Rozencwajg: Gold Stock Gains, Silver and Uranium Prices — Plus PGMs Bull Case

Related Posts

Placement Shares Issued & Drilling Approval Expected August

July 10, 2025

Large High Grade Rubidium Resource Identified at Seymour

July 24, 2025

Matt Geiger: Hard Assets at Turning Point, How...

August 20, 2025

Manindi Ti-V-Fe Discovery Delivers High-Grade Concentrates

May 16, 2025

Gold Price Dips, Markets Stay Flat as Fed...

May 8, 2025

Cizzle Brands Strengthens U.S. Footprint of CWENCH Hydration...

April 11, 2025

Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

Popular

1

First the token, now the swipe: NYC’s subway system to stop selling MetroCards
March 20, 2025
2

AI that can match humans at any task will be here in five to 10 years, Google DeepMind CEO says
March 19, 2025
3

How new professional sports leagues like SailGP are putting women at the fore
March 21, 2025
4

Plummeting stock, boycotts and flagging sales: What’s fueling turmoil for Tesla?
March 18, 2025
5

Lebanon says it was hit by cross-border attack from Syria as tensions escalate
March 18, 2025

About us
Contact us
Privacy Policy
Terms & Conditions

Copyright © 2025 insiderfinancenews.com | All Rights Reserved